Showing results (111-120 of 284) with videos related to
Sort By:
Pageof 29
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1990
Can virostatic chemotherapy and/or adoptive allogeneic immunotherapy eradicate in vivo Friend's virus infection?G Mathé, M Trabaud, E Chenu, et al.Chronobiology International|January 1, 1986
Interindividual differences in the circadian hematologic time structure of cancer patientsF Bailleul, F Lévi, A Reinberg, et al.Cancer Letters|February 1, 1984
Experimental antitumor activity of 5'-nor-anhydrovinblastine navelbineR Maral, C Bourut, E Chenu, et al.Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1980
[Immune monitoring of the cancer patient: suppressor cells and NK cells]A Goutner, Y Thomas, R Huchet, et al.Medical Oncology and Tumor Pharmacotherapy|January 1, 1989
4'-O-tetrahydropyranyl adriamycin (THP-ADM)-induced modifications of murine peritoneal macrophagesA Bravo-Cuellar, G Mathé, S Orbach-ArbouysBiomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1986
Relationship between proliferative activity of bone marrow micrometastasis and plasmatic level of a new cancer marker: lipid associated sialic acid (LASA) in human breast cancerM Ginsbourg, M Musset, J L Misset, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 17, 2002
II. Glutamine and glutamateH Tapiero, G Mathé, P Couvreur, et al.Cancer Treatment Reports|April 1, 1983
Phase II clinical evaluation of 4'-epi-doxorubicinP Hurteloup, P Cappelaere, J P Armand, et al.Cellular Immunology|October 15, 1983
Reversal of immunological tolerance by aclacinomycin through inhibition of suppressor cell activityS Orbach-Arbouys, C E Andrade-Mena, G MathéBiomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 17, 2002
I. ArginineH Tapiero, G Mathé, P Couvreur, et al.Pageof 29